STARHEALTH Star Health and Allied Insurance Company Q1 FY26 results (Apr–Jun 2025) and concall
Star Health delivered a strong start to FY26 with significant growth in retail premiums and a substantial jump in IFRS-based profitability. The company is successfully pivoting towards a digital-first strategy and higher-value products like 'Super Star', while consciously exiting unviable large corporate segments. Despite industry-wide medical inflation pressures on claim ratios, management remains focused on risk-based pricing and long-term ROE targets.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 4,058 | 4,146 | 4,081 | 4,880 |
| EBITDA | 147 | 285 | -7 | 588 |
| Net profit | 111 | 215 | 1 | 438 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
